Robert J. Levinson and Stanley Besen. “Standards, Intellectual Property Disclosure, and Patent Royalties After Rambus.” North Carolina Journal of Law & Technology, vol. 10, no. 2 (Spring 2009).
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...